Statistics for Axsome Therapeutics (id:6417 AXSM)

Valuation metrics

Market cap

4.78B

Enterprise value

4.62B

Trailing P/E (ttm)

-18.72

Forward P/E

-45.69

PEG ratio

-45.69

Price/Sales (ttm)

14.13

Price/Book (mrq)

51.45

Enterprise Value/Revenue

13.66

Enterprise Value/EBITDA

-18.90

Overview

Shares outstanding

48.46M

Float

36.12M

Shares short

7.58M

% Held by insiders

0.17%

% Held by institutions

0.81%

Average volume (10 days)

759.05K

Average volume (90 days)

Price summary

52-Week low

60.28

52-Week high

105.00

52-Week change

36.61%

Beta

1.25

50-Day moving average

90.89

200-Day moving average

82.62

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-91.87%

Operating margin

-44.13%

Operational effectiveness

Return on assets

-26.44%

Return on equity

-171.61%

Income statement

Revenue (ttm)

7.11

Revenue per share (ttm)

7.11

Quarterly revenue growth (yoy)

Gross profit (ttm)

244.54M

EBITDA

-244,623,008.00

Net income to common (ttm)

-310,955,008.00

Diluted EPS (ttm)

-6.58

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

327.34M

Total cash per share (mrq)

6.76

Total debt (mrq)

192.30M

Total Debt/Equity (mrq)

207.00

Current ratio (mrq)

244.20%

Book value per share (mrq)

1.92

Cash flow

Cash flow statement

-132,570,000.00

Levered free cash flow (LFCF)

-42,439,752.00